Pediatric Infectious Disease
9
2
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
RELAX: Reducing Length of Antibiotics for Children With Ear Infections
Explorative Proteomics in Pediatric Neuroborreliosis
Evaluation of Xpert MTB/RIF Ultra in Stools and Urine to Improve Tuberculosis Diagnosis in Children
Airway Microbiome Changes After Artificial Airway Exchange in Critically-ill Pediatric Patients.
Role of CBC Parameters in Early Diagnosis of Pediatric Pneumonia
CRP for Respiratory Diagnosis in Kyrgyz Pediatric Practice
Next Generation Sequencing Detection of Lyme Disease